JPWO2022218891A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022218891A5 JPWO2022218891A5 JP2024505491A JP2024505491A JPWO2022218891A5 JP WO2022218891 A5 JPWO2022218891 A5 JP WO2022218891A5 JP 2024505491 A JP2024505491 A JP 2024505491A JP 2024505491 A JP2024505491 A JP 2024505491A JP WO2022218891 A5 JPWO2022218891 A5 JP WO2022218891A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- composition
- alkyl
- independently selected
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2021/059460 | 2021-04-12 | ||
| PCT/EP2021/059460 WO2022218503A1 (en) | 2021-04-12 | 2021-04-12 | Lnp compositions comprising rna and methods for preparing, storing and using the same |
| EPPCT/EP2021/087882 | 2021-12-30 | ||
| EP2021087882 | 2021-12-30 | ||
| PCT/EP2022/059555 WO2022218891A2 (en) | 2021-04-12 | 2022-04-11 | Rna compositions comprising a buffer substance and methods for preparing, storing and using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024514364A JP2024514364A (ja) | 2024-04-01 |
| JPWO2022218891A5 true JPWO2022218891A5 (https=) | 2025-04-17 |
| JP2024514364A5 JP2024514364A5 (https=) | 2025-04-17 |
Family
ID=81393053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505491A Pending JP2024514364A (ja) | 2021-04-12 | 2022-04-11 | 緩衝物質を含むｒｎａ組成物ならびにその製造、保存および使用のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240226132A1 (https=) |
| EP (1) | EP4322925A2 (https=) |
| JP (1) | JP2024514364A (https=) |
| AU (1) | AU2022256732A1 (https=) |
| CA (1) | CA3215103A1 (https=) |
| WO (1) | WO2022218891A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024089229A1 (en) * | 2022-10-28 | 2024-05-02 | CureVac SE | Improved formulations comprising lipid-based carriers encapsulating rna |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| PT1309726E (pt) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | Mediadores de interferência por rna específicos de sequência de rna |
| US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
| ES2655912T3 (es) | 2002-11-08 | 2018-02-22 | Ablynx N.V. | Anticuerpos de dominio simple dirigidos contra factor de necrosis tumoral-alfa y usos para los mismos |
| ES2567634T3 (es) | 2004-02-09 | 2016-04-25 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| US20070269422A1 (en) | 2006-05-17 | 2007-11-22 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
| WO2008012629A2 (en) | 2006-07-24 | 2008-01-31 | Biorexis Pharmaceutical Corporation | Exendin fusion proteins |
| CN101646689A (zh) | 2006-09-08 | 2010-02-10 | 埃博灵克斯股份有限公司 | 具有长半衰期的血清清蛋白结合蛋白 |
| JP2011507543A (ja) | 2007-12-27 | 2011-03-10 | ノバルティス アーゲー | 改善されたフィブロネクチンベースの結合分子およびそれらの使用 |
| PL2274331T3 (pl) | 2008-05-02 | 2014-04-30 | Novartis Ag | Ulepszone cząsteczki wiążące oparte na fibronektynie i ich zastosowanie |
| US10233228B2 (en) | 2010-04-09 | 2019-03-19 | Albumedix Ltd | Albumin derivatives and variants |
| EA022983B1 (ru) | 2010-04-13 | 2016-04-29 | Бристол-Майерс Сквибб Компани | Белки на основе структурного домена фибронектина, связывающие pcsk9 |
| US20140220017A1 (en) | 2011-09-23 | 2014-08-07 | Universitat Stuttgart | Serum half-life extension using igbd |
| EP2780364A2 (en) | 2011-11-18 | 2014-09-24 | Eleven Biotherapeutics, Inc. | Proteins with improved half-life and other properties |
| FR3009192B1 (fr) | 2013-07-31 | 2015-09-04 | Oreal | Composition cosmetique anhydre comprenant de l'alkylcellulose, au moins un ester ramifie de dextrine et au moins un alcool gras |
| WO2016005004A1 (en) | 2014-07-11 | 2016-01-14 | Biontech Rna Pharmaceuticals Gmbh | Stabilization of poly(a) sequence encoding dna sequences |
| US11219634B2 (en) * | 2015-01-21 | 2022-01-11 | Genevant Sciences Gmbh | Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells |
| US20180303925A1 (en) | 2015-04-27 | 2018-10-25 | The Trustees Of The University Of Pennsylvania | Nucleoside-Modified RNA For Inducing an Adaptive Immune Response |
| IL307179A (en) | 2015-10-28 | 2023-11-01 | Acuitas Therapeutics Inc | Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| BR112018069417A2 (pt) | 2016-04-22 | 2019-01-22 | Biontech Rna Pharmaceuticals Gmbh | método para fornecer rna fita simples e ssrna |
| WO2017218704A1 (en) * | 2016-06-14 | 2017-12-21 | Modernatx, Inc. | Stabilized formulations of lipid nanoparticles |
| BR112019008481A2 (pt) * | 2016-10-26 | 2020-03-03 | Curevac Ag | Vacinas de mrna de nanopartículas lipídicas |
| ES3063077T3 (en) | 2016-10-26 | 2026-04-15 | Acuitas Therapeutics Inc | Lipid nanoparticle formulations |
-
2022
- 2022-04-11 AU AU2022256732A patent/AU2022256732A1/en active Pending
- 2022-04-11 US US18/554,947 patent/US20240226132A1/en active Pending
- 2022-04-11 JP JP2024505491A patent/JP2024514364A/ja active Pending
- 2022-04-11 EP EP22719594.8A patent/EP4322925A2/en active Pending
- 2022-04-11 CA CA3215103A patent/CA3215103A1/en active Pending
- 2022-04-11 WO PCT/EP2022/059555 patent/WO2022218891A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023549265A5 (https=) | ||
| JP5645954B2 (ja) | イリノテカン又はその塩酸塩のリポソーム及びその製造方法 | |
| CN100377704C (zh) | 脂质体制剂 | |
| JPWO2022101486A5 (https=) | ||
| EP1003556B1 (en) | Cationic reagents for transfection | |
| JPWO2023044343A5 (https=) | ||
| JP2004525138A (ja) | 治療剤の改良された細胞内送達のためのリポソーム組成物 | |
| AU2003242765B2 (en) | Camptothecin-carboxylate formulations | |
| AU2001275269A1 (en) | Liposomal benzoquinazoline thymidylate synthase inhibitor formulations | |
| JPWO2022101470A5 (https=) | ||
| WO2024046448A1 (en) | Lyophilized formulations and liquid formulations of lipid nanoparticles | |
| EP1448165B1 (en) | Lipid carrier compositions and methods for improved drug retention | |
| JP5903097B2 (ja) | エラシタラビン誘導体の非経口製剤 | |
| TW200520787A (en) | Liposome and drug deliver system | |
| JPWO2022218891A5 (https=) | ||
| JPWO2019045897A5 (https=) | ||
| US7008791B1 (en) | Liposome-entrapped DNA oral vaccines | |
| KR101971451B1 (ko) | ２―하이드록시올레산이 포함된 지질 비히클의 용도 | |
| WO2025012723A1 (en) | Liposome encapsulated apomorphine | |
| JPWO1991007973A1 (ja) | 脂肪乳剤 | |
| JPWO2023009422A5 (https=) | ||
| JP2611307B2 (ja) | リポソーム製剤およびその製造法 | |
| WO2017222042A1 (ja) | 眼用医薬組成物 | |
| JPWO2023036960A5 (https=) | ||
| JPWO2023009421A5 (https=) |